Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Neoadjuvant Chemo-hypoRT Plus PD-1 Antibody (Tislelizumab) in Resectable LA-G/GEJ [Phase 2]
This clinical trial update describes a Phase 2 study evaluating neoadjuvant chemotherapy and hypofractionated radiotherapy combined with the…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. [Phase 1]
Pfizer's Phase 1 study of PF-06940434 in advanced or metastatic solid tumors has been terminated. The trial enrolled several solid tumor typ…
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: DESI - Düsseldorfer ESD Study
An ongoing clinical trial (DESI Düsseldorfer ESD study) is currently enrolling by invitation for patients with esophageal, gastric, duodenal…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Feasibility and Safety of Robotic Assisted Proximal Gastrectomy With Double-flap Technique for Proximal Early Gastric Cancer [NA]
Clinical trial evaluating the feasibility and safety of robotic-assisted proximal gastrectomy with a double-flap technique for proximal earl…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC [Phase 1, Phase 2]
Status update on ONC-392 showing safety, pharmacokinetics, and preliminary efficacy in monotherapy and in combination with anti-PD-1 across …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Savolitinib for Treating Gastric Cancer and Esophagogastric Junction Adenocarcinoma Patients [Phase 2]
Ongoing phase 2 trial of savolitinib for gastric cancer and esophagogastric junction adenocarcinoma; the study is currently not recruiting.
-
FDA approval · 2025-05-22FDA Approved: HERZUMA — Supplemental Application (Cephalon, Inc.)
FDA approved a supplemental application for Herzuma (trastuzumab) from Cephalon, Inc.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors [Phase 1]
This ClinicalTrials.gov update describes a Phase 1 study evaluating MNPR-101-DFO*-89Zr as a diagnostic imaging agent for adults with various…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients [Phase 2]
Phase 2 trial of the COMBO Endoscopy Oropharyngeal Airway used during sedated gastrointestinal endoscopy in obese patients has completed rec…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Reduced Port Laparoscopic Gastrectomy for Gastric Cancer [NA]
This clinical trial update indicates that a reduced-port laparoscopic gastrectomy for gastric cancer is currently recruiting at Nanchong Cen…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors [Phase 1]
Phase 1 dose-escalation study of MNPR-101-PCTA-177Lu in solid tumors is currently recruiting across multiple cancer indications.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) [Phase 1, Phase 2]
KL264-01, a Trop2-targeted antibody-drug conjugate, is being studied in a Phase 1/2 trial for advanced unresectable or metastatic solid tumo…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Machine Learning Model Guided by TLS Predicts Survival and Immune Features in Gastric Cancer
A completed trial study evaluates a machine learning model guided by tertiary lymphoid structures for predicting survival and tumor immune f…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer
This ClinicalTrials.gov update describes a study evaluating multigene methylation dynamics to surveil treatment response in gastric cancer, …
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC) [Phase 2]
Phase 2 trial update evaluating node-sparing short-course radiotherapy combined with first-line therapy and a PD-1 inhibitor for unresectabl…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer [NA]
A clinical trial is evaluating the value of spectral CT for the accurate staging of gastric cancer and is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression [Phase 2, Phase 3]
A clinical trial update describing a Phase 2/3 study evaluating Fruquintinib plus Sintilimab and SBRT for second-line or higher treatment of…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer [NA]
This clinical trial update describes a study evaluating circulating biomarker signatures for detecting gastric preneoplasia and gastric canc…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
A completed clinical trial evaluating PET imaging with the radiotracer 18F-BMS-986229 in patients with cancers of the esophagus, stomach, or…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol) [NA]
This entry describes a clinical trial protocol investigating chemoimmunotherapy followed by surgery for oligometastatic esophagogastric canc…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study [NA]
The RT-CAMSS study, a real-time monitoring trial of chemotherapy side-effects in gastrointestinal cancers, has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Totally Laparoscopic Distal Gastrectomy VS Pylorus-Preserving Gastrectomy for Early Gastric Cancer in the Middle Stomach
This clinical trial update reports the completion of a study comparing totally laparoscopic distal gastrectomy with pylorus-preserving gastr…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Artificial Intelligence to Solve the MissINg of Gastric Cancer (AIMING) [NA]
This entry describes a clinical trial named AIMING investigating artificial intelligence for gastric cancer, which is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer [Phase 3]
Phase 3 clinical trial comparing Billroth II and Roux-en-Y gastric bypass procedures for gastric cancer, focusing on quality of life; recrui…
-
EMA approval · 2025-05-13EMA Authorised: Kanjinti (trastuzumab) — Amgen Europe B.V.
The European Medicines Agency authorised Kanjinti (trastuzumab) by Amgen Europe B.V. for gastric and breast cancers.